Abstract
Background:Although concerns arise about the generalizability of results from Randomized Controlled Trials (RCTs), few studies systematically examine this issue. Objectives: This study compared the characteristics of 427 opioid-using pregnant women who did (n = 208) and did not consent (n = 219) to enrollment in a multicenter clinical trial of agonist medications (i.e., the MOTHER study). Methods: Logistic regression models were used to compare consenters and non-consenters to examine the effect of screening variables on the likelihood of consenting. Results: Of nine characteristics examined, most differences did not reach statistical significance. Consenting participants were less likely than non-consenting women to be currently enrolled in a methadone maintenance program (74.5% vs. 84.5%, p = .01). Conclusion and Scientific Significance: These data show that the recruited sample of drug-dependent pregnantwomen enrolled in an intensiveRCTis representative of the larger population of treated opioid-dependent patients and supports the generalizability of randomized controlled trials in this population.
Original language | English (US) |
---|---|
Pages (from-to) | 429-433 |
Number of pages | 5 |
Journal | American Journal of Drug and Alcohol Abuse |
Volume | 35 |
Issue number | 6 |
DOIs | |
State | Published - Dec 15 2009 |
Externally published | Yes |
Keywords
- Buprenorphine
- Methadone
- Opiates
- Opioids
- Pregnant women
- Substance abuse
- Substance use
- Treatment acceptance
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Clinical Psychology
- Psychiatry and Mental health